Charlotte Rivera-Garcia, MS, Sara L. Bristow, PhD, Sarah Yarnall, MS, CGC, Neha Kumar, ScM, Sally Rodriguez, ScM, CGC, Nicholas De Veaux, BSE, Alexander Bisignano, AB, Bo Chu, BSc, Renata Prates, BSc and Santiago Munne, PhD

Genet Med 2015; doi:10.1038/gim.2015.101

Received 27 February 2015; Accepted 09 June 2015; Published online 30 July 2015

The authors have requested a retraction of the above article based on an error in the analysis of sample number. The authors have provided the following explanation:

“During routine quality control using one of the validation samples, it was discovered that there was an error regarding how the sample was entered into the Supplementary Table 2. This prompted further investigation, which resulted in the discovery that all source material from the original data analysis was lost in a data migration when moving to a new engineering platform. In order to rectify the identified sample error, and reconfirm the accuracy of all other samples, the original listing of all validation samples and mutations would be needed. Due to the aforementioned data migration, we unfortunately no longer have access to this raw data for the validation samples.”

While this error does not affect the clinical validity of the expanded carrier screening panel, due to the nature of the error, the authors, editors and publisher think it prudent to retract the paper. We apologize for any adverse consequences this may have caused.